Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis.
Cohen
J D
JD
Zaltni
S
S
Kaiser
M J
MJ
Bozonnat
M C
MC
Jorgensen
C
C
Daurès
J P
JP
Sany
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept; D008727:Methotrexate